(676124, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0005402', 'abnormal action potential', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676125, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676126, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676127, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676128, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003464', 'abnormal single cell response threshold', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676129, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0005645', 'abnormal hypothalamus physiology', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676130, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003483', 'decreased nerve fiber response threshold', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676131, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676132, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676133, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676134, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676135, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676136, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4642857142857143, 5.059610039003922, 1.532678916461666, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676137, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003880', 'abnormal central pattern generator function', 0.4642857142857143, 5.059610039003922, 1.532678916461666, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676138, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676139, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676140, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0006080', 'brain ischemia', 0.4642857142857143, 5.059610039003922, 1.532678916461666, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676141, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676142, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0011397', 'endoneurial edema', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676143, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004994', 'abnormal brain wave pattern', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676144, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676145, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003471', 'abnormal summary potential threshold', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676146, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0005671', 'abnormal response to transplant', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676147, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676148, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676149, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4642857142857143, 5.059610039003922, 1.532678916461666, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676150, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676151, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676152, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676153, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0021015', 'increased tau protein phosphorylation', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676154, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676155, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003635', 'abnormal synaptic transmission', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676156, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676157, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676158, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0005000', 'abnormal immune tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676159, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0008814', 'decreased nerve conduction velocity', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676160, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003481', 'decreased nerve fiber response intensity', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676161, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676162, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676163, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676164, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003463', 'abnormal single cell response', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676165, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001800', 'abnormal humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676166, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676167, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676168, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676169, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676170, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676171, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0014120', 'focal seizures', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676172, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676173, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676174, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676175, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676176, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676177, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676178, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003477', 'abnormal nerve fiber response', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676179, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676180, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001912', 'increased cerebrospinal fluid production', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676181, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676182, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0011994', 'increased nerve conduction velocity', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676183, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003633', 'abnormal nervous system physiology', 0.48148148148148145, 5.059610039003922, 1.5608038112774407, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676184, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676185, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003997', 'tonic-clonic seizures', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676186, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676187, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676188, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676189, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0003499', 'thyroid gland hypoplasia', 0.425531914893617, 11.668547812575419, 2.228304174638854, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(676190, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0004698', 'abnormal thyroid parafollicular C-cell morphology', 0.4186046511627907, 11.668547812575419, 2.2100923932404903, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(676191, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0002951', 'small thyroid gland', 0.47619047619047616, 11.668547812575419, 2.35721262072848, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(676192, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0020169', 'increased thyroid gland weight', 0.5348837209302325, 14.192109768632433, 2.7552002614867064, 'UPHENO:0001070', 'increased size of the thyroid gland'),
(676193, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0003113', 'small parathyroid gland', 0.4090909090909091, 7.914822368502075, 1.7994115365928876, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(676194, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0005355', 'enlarged thyroid gland', 0.5897435897435898, 14.192109768632433, 2.89304437591067, 'UPHENO:0001070', 'increased size of the thyroid gland'),
(676195, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0004661', 'absent thyroid parafollicular C-cells', 0.4090909090909091, 11.668547812575419, 2.1848333649084584, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(676196, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0003493', 'parathyroid gland hyperplasia', 0.4772727272727273, 10.052558416233639, 2.1903908261733194, 'UPHENO:0083530', 'anatomical entity hyperplasia'),
(676197, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0031094', 'organomegaly', 0.43243243243243246, 5.9605885577567275, 1.6054755709009296, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(676198, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0008299', 'adrenal cortical hyperplasia', 0.4666666666666667, 10.052558416233639, 2.1659164174953056, 'UPHENO:0083530', 'anatomical entity hyperplasia'),
(676199, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0000642', 'enlarged adrenal glands', 0.46511627906976744, 7.914822368502075, 1.9186747326047344, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(676200, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0005491', 'pancreatic islet hyperplasia', 0.42, 10.052558416233639, 2.0547687302512, 'UPHENO:0083530', 'anatomical entity hyperplasia'),
(676201, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0009171', 'enlarged pancreatic islets', 0.4166666666666667, 7.914822368502075, 1.8159963253108558, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(676202, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0020168', 'decreased thyroid gland weight', 0.4166666666666667, 11.668547812575419, 2.2049705036363694, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(676203, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0013328', 'visceromegaly', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(676204, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0008301', 'adrenal medulla hyperplasia', 0.45652173913043476, 10.052558416233639, 2.142244489055642, 'UPHENO:0083530', 'anatomical entity hyperplasia'),
(676205, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0009078', 'adrenal gland hyperplasia', 0.4666666666666667, 10.052558416233639, 2.1659164174953056, 'UPHENO:0083530', 'anatomical entity hyperplasia'),
(676206, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0004663', 'athyroidism', 0.41025641025641024, 11.668547812575419, 2.187943449564563, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(676207, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0020145', 'enlarged adrenal gland x-zone', 0.40816326530612246, 7.914822368502075, 1.7973702295981608, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(676208, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0000681', 'abnormal thyroid gland morphology', 0.42105263157894735, 11.668547812575419, 2.2165452314784035, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(676209, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0003498', 'thyroid gland hyperplasia', 0.625, 15.87018167374507, 3.149422732198818, 'UPHENO:0083525', 'thyroid gland hyperplasia'),
(676210, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0008300', 'enlarged adrenal medulla', 0.45454545454545453, 7.914822368502075, 1.896746301205648, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(676211, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0003112', 'enlarged parathyroid gland', 0.47619047619047616, 7.914822368502075, 1.9413817328439134, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(676212, 'HP:0008249', 'Thyroid hyperplasia', 'MP:0013937', 'absent lobe of thyroid gland', 0.41025641025641024, 11.668547812575419, 2.187943449564563, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(676213, 'HP:0031571', 'Paramedian facial cleft', 'MP:0030049', 'prominent forehead', 0.41509433962264153, 6.5236679405794336, 1.6455812455519228, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(676214, 'HP:0031571', 'Paramedian facial cleft', 'MP:0030063', 'abnormal face size', 0.43478260869565216, 11.592196926445306, 2.245013501116109, 'UPHENO:0020809', 'abnormal face morphology'),
(676215, 'HP:0031571', 'Paramedian facial cleft', 'MP:0030072', 'round face', 0.4807692307692308, 12.700256672302759, 2.471010447350393, 'UPHENO:0005983', 'abnormal shape of face'),
(676216, 'HP:0031571', 'Paramedian facial cleft', 'MP:0009578', 'otocephaly', 0.43478260869565216, 6.5236679405794336, 1.684154792609432, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(676217, 'HP:0031571', 'Paramedian facial cleft', 'MP:0030071', 'abnormal face shape', 0.5681818181818182, 12.700256672302759, 2.686271566213057, 'UPHENO:0005983', 'abnormal shape of face'),
(676218, 'HP:0031571', 'Paramedian facial cleft', 'MP:0008799', 'oblique facial cleft', 0.6086956521739131, 13.437222266468964, 2.859926357599816, 'UPHENO:0041242', 'split face'),
(676219, 'HP:0031571', 'Paramedian facial cleft', 'MP:0030074', 'coarse facial features', 0.5555555555555556, 12.700256672302759, 2.6562564167036493, 'UPHENO:0005983', 'abnormal shape of face'),
(676220, 'HP:0031571', 'Paramedian facial cleft', 'MP:0000108', 'midline facial cleft', 0.5714285714285714, 13.437222266468964, 2.7709948978113528, 'UPHENO:0041242', 'split face'),
(676221, 'HP:0031571', 'Paramedian facial cleft', 'MP:0008797', 'facial cleft', 0.6222222222222222, 13.437222266468964, 2.8915287131785923, 'UPHENO:0041242', 'split face'),
(676222, 'HP:0031571', 'Paramedian facial cleft', 'MP:0000447', 'flattened snout', 0.4074074074074074, 6.5236679405794336, 1.6302731803161972, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(676223, 'HP:0031571', 'Paramedian facial cleft', 'MP:0000448', 'pointed snout', 0.43137254901960786, 6.5236679405794336, 1.677537262920036, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(676224, 'HP:0031571', 'Paramedian facial cleft', 'MP:0003749', 'down-turned corners of mouth', 0.4074074074074074, 6.5236679405794336, 1.6302731803161972, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(676225, 'HP:0031571', 'Paramedian facial cleft', 'MP:0030045', 'abnormal forehead shape', 0.4489795918367347, 6.5236679405794336, 1.7114303284795866, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(676226, 'HP:0031571', 'Paramedian facial cleft', 'MP:0031501', 'abnormal mouth shape', 0.41509433962264153, 6.5236679405794336, 1.6455812455519228, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(676227, 'HP:0031571', 'Paramedian facial cleft', 'MP:0008798', 'lateral facial cleft', 0.6086956521739131, 13.437222266468964, 2.859926357599816, 'UPHENO:0041242', 'split face'),
(676228, 'HP:0031571', 'Paramedian facial cleft', 'MP:0012175', 'flat face', 0.4807692307692308, 12.700256672302759, 2.471010447350393, 'UPHENO:0005983', 'abnormal shape of face'),
(676229, 'HP:0031571', 'Paramedian facial cleft', 'MP:0012546', 'triangular face', 0.5, 12.700256672302759, 2.519946097866258, 'UPHENO:0005983', 'abnormal shape of face'),
(676230, 'HP:0031571', 'Paramedian facial cleft', 'MP:0006290', 'proboscis', 0.43478260869565216, 6.5236679405794336, 1.684154792609432, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(676231, 'HP:0031571', 'Paramedian facial cleft', 'MP:0030099', 'facial asymmetry', 0.4716981132075472, 12.700256672302759, 2.447588018759851, 'UPHENO:0005983', 'abnormal shape of face'),
(676232, 'HP:0031571', 'Paramedian facial cleft', 'MP:0011495', 'abnormal head shape', 0.4444444444444444, 6.5236679405794336, 1.7027648027813058, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(676233, 'HP:0031571', 'Paramedian facial cleft', 'MP:0030073', 'square face', 0.5102040816326531, 12.700256672302759, 2.545529962894015, 'UPHENO:0005983', 'abnormal shape of face'),
(676234, 'HP:0031571', 'Paramedian facial cleft', 'MP:0030048', 'sloping forehead', 0.4230769230769231, 6.5236679405794336, 1.6613287933085112, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(676235, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0013722', 'abnormal circulating tyrosine level', 0.4098360655737705, 9.920646740728058, 2.016392528295827, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676236, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0030693', 'abnormal circulating serine level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676237, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0030666', 'abnormal circulating proline level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676238, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0030626', 'decreased circulating cysteine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676239, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.43859649122807015, 9.920646740728058, 2.0859436356710397, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676240, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0011651', 'abnormal circulating histidine level', 0.4098360655737705, 9.920646740728058, 2.016392528295827, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676241, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0030660', 'abnormal circulating arginine level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676242, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0005328', 'abnormal circulating creatinine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676243, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0030672', 'abnormal circulating alanine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676244, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0030643', 'abnormal circulating methionine level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676245, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0030738', 'abnormal circulating glutamic acid level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676246, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0030717', 'abnormal circulating lysine level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676247, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0030624', 'abnormal circulating cysteine level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676248, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0005311', 'abnormal circulating amino acid level', 0.44642857142857145, 9.920646740728058, 2.104485721526934, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676249, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0030745', 'increased circulating homocitrulline level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676250, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0030702', 'abnormal circulating threonine level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676251, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0020835', 'abnormal circulating citrulline level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676252, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0030625', 'increased circulating cysteine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676253, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0030708', 'abnormal circulating glutamine level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676254, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0006076', 'abnormal circulating homocysteine level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676255, 'HP:0012113', 'Abnormal circulating creatine concentration', 'MP:0030637', 'abnormal circulating taurine level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(676256, 'HP:0032328', 'Temporomandibular joint adhesion', 'MP:0030050', 'large mandible', 0.4025974025974026, 11.410750055107773, 2.1433474599034468, 'UPHENO:0083646', 'abnormal mandible morphology'),
(676257, 'HP:0032328', 'Temporomandibular joint adhesion', 'MP:0004592', 'small mandible', 0.4025974025974026, 11.410750055107773, 2.1433474599034468, 'UPHENO:0083646', 'abnormal mandible morphology'),
(676258, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0003670', 'dilated renal glomerular capsule', 0.4074074074074074, 9.692263881549227, 1.987133639162305, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(676259, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0020518', 'renal glomerular protein deposits', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676260, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.41304347826086957, 9.692263881549227, 2.000831423648002, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(676261, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0011348', 'abnormal renal glomerulus basement membrane morphology', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676262, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0011567', 'increased renal glomerulus lobularity', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676263, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0011561', 'renal glomerulus lipidosis', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676264, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0021200', 'decreased susceptibility to glomerulonephritis', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676265, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0011377', 'renal glomerulus fibrosis', 0.4423076923076923, 9.804092483287297, 2.082408586578051, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676266, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0021199', 'abnormal susceptibility to glomerulonephritis', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676267, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0011483', 'renal glomerular synechia', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676268, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0011506', 'glomerular crescent', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676269, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0000523', 'cortical renal glomerulopathies', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676270, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0011349', 'abnormal renal glomerulus basement membrane thickness', 0.4339622641509434, 9.804092483287297, 2.0626696710798362, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676271, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0005325', 'abnormal renal glomerulus morphology', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676272, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0011294', 'renal glomerulus hypertrophy', 0.41818181818181815, 9.804092483287297, 2.0248193055884713, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676273, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0020519', 'renal glomerular immunoglobulin deposits', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676274, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0021201', 'increased susceptibility to glomerulonephritis', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676275, 'HP:0033322', 'Glomerular capillary wall duplication without cellular interposition', 'MP:0011855', 'abnormal glomerular filtration barrier morphology', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(676276, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012037', 'abnormal b-wave latency', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676277, 'HP:0007939', 'Blue cone monochromacy', 'MP:0005257', 'abnormal intraocular pressure', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676278, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012146', 'increased b-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676279, 'HP:0007939', 'Blue cone monochromacy', 'MP:0002001', 'blindness', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676280, 'HP:0007939', 'Blue cone monochromacy', 'MP:0013468', 'chromodacryorrhea', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676281, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012149', 'decreased b-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676282, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020974', 'abnormal FO-wave shape', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676283, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676284, 'HP:0007939', 'Blue cone monochromacy', 'MP:0006153', 'hypermetropia', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676285, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020220', 'decreased tear production', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676286, 'HP:0007939', 'Blue cone monochromacy', 'MP:0005551', 'abnormal eye electrophysiology', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676287, 'HP:0007939', 'Blue cone monochromacy', 'MP:0003100', 'myopia', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676288, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012148', 'decreased a-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676289, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020979', 'decreased FO-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676290, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012032', 'abnormal ERG latency', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676291, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012153', 'increased b-wave latency', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676292, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012152', 'decreased a-wave latency', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676293, 'HP:0007939', 'Blue cone monochromacy', 'MP:0004021', 'abnormal rod electrophysiology', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676294, 'HP:0007939', 'Blue cone monochromacy', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676295, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020962', 'increased c-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676296, 'HP:0007939', 'Blue cone monochromacy', 'MP:0005260', 'ocular hypotension', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676297, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020860', 'abnormal cornea physiology', 0.45, 8.795504987450572, 1.98946657281613, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676298, 'HP:0007939', 'Blue cone monochromacy', 'MP:0010749', 'absent visual evoked potential', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676299, 'HP:0007939', 'Blue cone monochromacy', 'MP:0014132', 'abnormal tear film physiology', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676300, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012154', 'decreased b-wave latency', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676301, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020959', 'decreased c-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676302, 'HP:0007939', 'Blue cone monochromacy', 'MP:0003101', 'high myopia', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676303, 'HP:0007939', 'Blue cone monochromacy', 'MP:0005258', 'ocular hypertension', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676304, 'HP:0007939', 'Blue cone monochromacy', 'MP:0008145', 'hemeralopia', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676305, 'HP:0007939', 'Blue cone monochromacy', 'MP:0004022', 'abnormal cone electrophysiology', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676306, 'HP:0007939', 'Blue cone monochromacy', 'MP:0006150', 'double vision', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676307, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012033', 'abnormal ERG implicit time', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676308, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020219', 'increased tear production', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676309, 'HP:0007939', 'Blue cone monochromacy', 'MP:0006190', 'retina ischemia', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676310, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676311, 'HP:0007939', 'Blue cone monochromacy', 'MP:0006152', 'tunnel vision', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676312, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012145', 'increased a-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676313, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020960', 'increased c-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676314, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020977', 'decreased FO-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676315, 'HP:0007939', 'Blue cone monochromacy', 'MP:0003011', 'delayed dark adaptation', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676316, 'HP:0007939', 'Blue cone monochromacy', 'MP:0005253', 'abnormal eye physiology', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676317, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012147', 'increased a-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676318, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012040', 'abnormal c-wave shape', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676319, 'HP:0007939', 'Blue cone monochromacy', 'MP:0013145', 'eye discharge', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676320, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020980', 'increased FO-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676321, 'HP:0007939', 'Blue cone monochromacy', 'MP:0010748', 'abnormal visual evoked potential', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676322, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012030', 'abnormal a-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676323, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012038', 'abnormal a-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676324, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020439', 'absent b-wave', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676325, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012031', 'abnormal b-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676326, 'HP:0007939', 'Blue cone monochromacy', 'MP:0002090', 'abnormal vision', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676327, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012143', 'decreased a-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676328, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020861', 'abnormal corneal wound healing', 0.4090909090909091, 8.795504987450572, 1.896881949734822, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676329, 'HP:0007939', 'Blue cone monochromacy', 'MP:0031497', 'increased visual acuity', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676330, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012039', 'abnormal b-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676331, 'HP:0007939', 'Blue cone monochromacy', 'MP:0001999', 'photosensitivity', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676332, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020975', 'abnormal FO-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676333, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020978', 'abnormal FO-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676334, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020963', 'decreased c-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676335, 'HP:0007939', 'Blue cone monochromacy', 'MP:0003096', 'increased corneal light-scattering', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676336, 'HP:0007939', 'Blue cone monochromacy', 'MP:0011832', 'abnormal visual acuity', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676337, 'HP:0007939', 'Blue cone monochromacy', 'MP:0001337', 'dry eyes', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676338, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020961', 'abnormal c-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676339, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676340, 'HP:0007939', 'Blue cone monochromacy', 'MP:0006149', 'decreased visual acuity', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676341, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012036', 'abnormal a-wave latency', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676342, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020218', 'abnormal tear production', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676343, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012144', 'decreased b-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676344, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012035', 'abnormal b-wave shape', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676345, 'HP:0007939', 'Blue cone monochromacy', 'MP:0006251', 'eyelid apraxia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676346, 'HP:0007939', 'Blue cone monochromacy', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676347, 'HP:0007939', 'Blue cone monochromacy', 'MP:0014157', 'alacrima', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676348, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020958', 'abnormal c-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676349, 'HP:0007939', 'Blue cone monochromacy', 'MP:0020976', 'increased FO-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676350, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012034', 'abnormal a-wave shape', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676351, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012150', 'increased b-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676352, 'HP:0007939', 'Blue cone monochromacy', 'MP:0012151', 'increased a-wave latency', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(676353, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004877', 'abnormal systemic vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676354, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676355, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005251', 'blepharitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676356, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013557', 'abnormal merocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676357, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031102', 'rhinorrhea', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676358, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013752', 'stridor', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676359, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008007', 'abnormal cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676360, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000427', 'abnormal hair cycle', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676361, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003469', 'decreased single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676362, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008563', 'decreased interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676363, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008942', 'abnormal induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676364, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676365, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008693', 'increased interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676366, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002471', 'abnormal complement pathway', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676367, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676368, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002694', 'abnormal pancreas secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676369, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0021023', 'increased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676370, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676371, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001876', 'decreased inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676372, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013942', 'enthesitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676373, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676374, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031225', 'decreased CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676375, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676376, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676377, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676378, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008670', 'decreased interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676379, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031127', 'dry gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676380, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013636', 'abnormal bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676381, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011046', 'abnormal lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676382, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031223', 'increased CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676383, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004994', 'abnormal brain wave pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676384, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676385, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002136', 'abnormal kidney physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676386, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001598', 'abnormal blood viscosity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676387, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008652', 'decreased interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676388, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003116', 'rickets', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676389, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676390, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676391, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012555', 'decreased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676392, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009062', 'impaired lectin complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676393, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008004', 'abnormal stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676394, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001866', 'nasal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676395, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003898', 'abnormal QRS complex', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676396, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013145', 'eye discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676397, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004510', 'myositis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676398, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011929', 'abnormal aortic valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676399, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008260', 'abnormal autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676400, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676401, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676402, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676403, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020137', 'decreased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676404, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011431', 'increased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676405, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008691', 'decreased interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676406, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010513', 'abnormal ventricular activation time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676407, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008775', 'abnormal heart ventricle pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676408, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002635', 'reduced sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676409, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011809', 'abnormal anoikis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676410, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003466', 'decreased single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676411, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011194', 'abnormal hair follicle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676412, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009247', 'meteorism', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676413, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003303', 'peritoneal inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676414, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011566', 'abnormal complement protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676415, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006003', 'abnormal large intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676416, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676417, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003091', 'abnormal cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676418, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013135', 'poor circulation in tail', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676419, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676420, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000503', 'excessive digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676421, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004945', 'abnormal bone resorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676422, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676423, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676424, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020846', 'abnormal cell motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676425, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001845', 'abnormal inflammatory response', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676426, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008748', 'abnormal central T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676427, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676428, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003278', 'esophageal inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676429, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030941', 'enhanced autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676430, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008943', 'increased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676431, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676432, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676433, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001924', 'infertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676434, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001919', 'abnormal reproductive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676435, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009384', 'cardiac valve regurgitation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676436, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003473', 'decreased summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676437, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001963', 'abnormal hearing physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676438, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010560', 'intraventricular block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676439, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009788', 'increased susceptibility to bacterial infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676440, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676441, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031014', 'polyspermy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676442, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001954', 'respiratory distress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676443, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009790', 'decreased susceptibility to viral infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676444, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001935', 'decreased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676445, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676446, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676447, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676448, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001846', 'increased inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676449, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676450, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676451, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002106', 'abnormal muscle physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676452, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011953', 'prolonged PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676453, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676454, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010695', 'abnormal blood pressure regulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676455, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013634', 'increased femur fracture load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676456, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002338', 'abnormal pulmonary ventilation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676457, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020155', 'enhanced humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676458, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002500', 'granulomatous inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676459, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003824', 'decreased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676460, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676461, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676462, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676463, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031066', 'cytokine storm', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676464, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031009', 'abnormal sperm-egg fusion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676465, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676466, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009732', 'ventricular premature beat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676467, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676468, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003566', 'abnormal cell adhesion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676469, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001665', 'chronic diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676470, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005004', 'abnormal lymphocyte anergy', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676471, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676472, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002634', 'abnormal sensorimotor gating', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676473, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010637', 'sinus bradycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676474, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003009', 'abnormal cytokine secretion', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676475, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008697', 'decreased interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676476, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031055', 'bronchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676477, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676478, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003481', 'decreased nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676479, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013498', 'trachea inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676480, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008672', 'increased interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676481, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676482, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676483, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676484, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676485, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676486, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676487, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676488, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010143', 'enhanced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676489, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003454', 'erythroderma', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676490, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676491, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676492, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031125', 'aspiration pneumonia', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676493, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676494, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676495, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676496, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000740', 'impaired smooth muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676497, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004212', 'abnormal salty taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676498, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676499, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010634', 'increased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676500, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676501, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005000', 'abnormal immune tolerance', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676502, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676503, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013640', 'increased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676504, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676505, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004046', 'abnormal mitosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676506, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030940', 'impaired autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676507, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676508, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012006', 'abnormal hippocampus physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676509, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676510, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000951', 'sporadic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676511, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008814', 'decreased nerve conduction velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676512, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031098', 'abnormal sputum production', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676513, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001854', 'atrial endocarditis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676514, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676515, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676516, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013625', 'increased femur yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676517, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001819', 'abnormal immune cell physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676518, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000751', 'myopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676519, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006336', 'abnormal otoacoustic response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676520, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676521, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013971', 'blood in lymph vessels', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676522, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010381', 'abnormal dosage compensation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676523, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005085', 'abnormal gallbladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676524, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002993', 'arthritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676525, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003929', 'decreased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676526, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001869', 'pancreas inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676527, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676528, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002292', 'abnormal gestational length', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676529, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676530, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030988', 'dysosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676531, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676532, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676533, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676534, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011164', 'panniculitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676535, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001847', 'brain inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676536, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004143', 'muscle hypertonia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676537, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003659', 'abnormal lymph circulation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676538, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003463', 'abnormal single cell response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676539, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676540, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005435', 'hemoperitoneum', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676541, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010896', 'decreased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676542, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676543, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676544, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003926', 'decreased cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676545, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004760', 'increased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676546, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012565', 'perivasculitis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676547, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002314', 'abnormal respiratory mechanics', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676548, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003927', 'increased cellular glucose import', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676549, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020142', 'increased anti-sperm antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676550, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008877', 'abnormal DNA methylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676551, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014274', 'decreased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676552, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676553, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011718', 'decreased interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676554, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676555, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676556, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005620', 'abnormal muscle contractility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676557, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001837', 'defective assembly of class I molecules', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676558, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030951', 'abnormal endocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676559, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676560, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001636', 'irregular heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676561, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031126', 'gangrene', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676562, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011928', 'abnormal mitral valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676563, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031104', 'crackles', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676564, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006194', 'keratoconjunctivitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676565, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013644', 'increased vertebra maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676566, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676567, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006138', 'congestive heart failure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676568, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000351', 'increased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676569, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031118', 'cardiovalvulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676570, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004010', 'increased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676571, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676572, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010520', 'sinoatrial block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676573, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676574, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008817', 'hematoma', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676575, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002987', 'abnormal urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676576, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010393', 'shortened QRS complex duration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676577, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013638', 'decreased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676578, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013641', 'increased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676579, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008661', 'decreased interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676580, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003474', 'abnormal summary potential intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676581, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676582, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010946', 'hyperpnea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676583, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001790', 'abnormal immune system physiology', 0.6086956521739131, 7.400946880077414, 2.122480668433333, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676584, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676585, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676586, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005043', 'defective assembly of class II molecules', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676587, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676588, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676589, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676590, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676591, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008712', 'decreased interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676592, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004781', 'abnormal surfactant composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676593, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005005', 'abnormal self tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676594, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010752', 'impaired mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676595, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010994', 'aerophagia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676596, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676597, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030990', 'nerve inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676598, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009046', 'muscle twitch', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676599, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676600, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006335', 'abnormal hearing electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676601, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030130', 'gum inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676602, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004512', 'anosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676603, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003897', 'abnormal ST segment', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676604, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676605, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020002', 'increased response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676606, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676607, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008005', 'decreased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676608, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012685', 'abnormal primitive streak elongation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676609, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004751', 'increased length of allograft survival', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676610, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009643', 'abnormal urine homeostasis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676611, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003899', 'abnormal QT interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676612, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000947', 'convulsive seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676613, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003123', 'paternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676614, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004742', 'abnormal vestibular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676615, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676616, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031402', 'decreased muscle fatigability', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676617, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013459', 'perioral dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676618, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013642', 'decreased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676619, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004085', 'abnormal heartbeat', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676620, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006190', 'retina ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676621, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003865', 'lymph node inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676622, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010751', 'decreased susceptibility to parasitic infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676623, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001947', 'abnormal mucociliary clearance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676624, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011764', 'ureteritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676625, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676626, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031095', 'pharyngitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676627, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008565', 'decreased interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676628, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010750', 'increased susceptibility to parasitic infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676629, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003467', 'abnormal single cell response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676630, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001984', 'abnormal olfaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676631, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676632, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005044', 'sepsis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676633, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009697', 'abnormal copulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676634, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000423', 'delayed hair regrowth', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676635, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676636, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676637, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011013', 'bronchiolectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676638, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031471', 'abnormal micropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676639, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004005', 'impaired contractility of intestinal smooth muscle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676640, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004156', 'abnormal QT variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676641, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004782', 'abnormal surfactant physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676642, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003699', 'abnormal female reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676643, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011900', 'podocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676644, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008001', 'hypochlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676645, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008711', 'increased interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676646, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031089', 'sneezing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676647, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676648, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000501', 'abnormal digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676649, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002499', 'chronic inflammation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676650, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011925', 'abnormal heart echocardiography feature', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676651, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011919', 'abnormal R wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676652, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676653, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676654, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009057', 'increased interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676655, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011717', 'increased interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676656, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031092', 'dysgeusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676657, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031091', 'hypogeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676658, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676659, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001666', 'abnormal intestinal absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676660, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676661, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005621', 'abnormal cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676662, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031170', 'abnormal vasculature physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676663, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676664, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008685', 'decreased interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676665, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005515', 'uveitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676666, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010570', 'prolonged ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676667, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676668, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676669, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001934', 'increased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676670, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676671, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010514', 'fragmented QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676672, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676673, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003746', 'stomatitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676674, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004144', 'hypotonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676675, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676676, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008555', 'abnormal interferon secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676677, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005037', 'mucous diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676678, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008721', 'abnormal chemokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676679, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002419', 'abnormal innate immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676680, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676681, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011804', 'increased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676682, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008009', 'delayed cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676683, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012201', 'decreased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676684, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001337', 'dry eyes', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676685, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010922', 'alveolitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676686, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012610', 'increased complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676687, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002935', 'chronic joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676688, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010072', 'increased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676689, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011938', 'prolonged PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676690, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003547', 'abnormal pulmonary pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676691, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676692, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008675', 'increased interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676693, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031470', 'abnormal macropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676694, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005551', 'abnormal eye electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676695, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003470', 'abnormal summary potential', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676696, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000505', 'decreased digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676697, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001629', 'abnormal heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676698, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005501', 'abnormal skin physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676699, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020097', 'low mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676700, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008737', 'abnormal spleen physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676701, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010211', 'abnormal acute phase protein level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676702, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676703, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003925', 'abnormal cellular glucose uptake', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676704, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676705, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008006', 'increased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676706, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004558', 'delayed allantois development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676707, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676708, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001849', 'ear inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676709, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006049', 'semilunar valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676710, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030924', 'early exit from telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676711, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004878', 'increased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676712, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000948', 'nonconvulsive seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676713, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011937', 'shortened PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676714, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013478', 'corneal limbitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676715, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676716, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011954', 'shortened PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676717, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031306', 'abnormal cartilage physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676718, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010559', 'heart block', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676719, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003465', 'increased single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676720, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011994', 'increased nerve conduction velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676721, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001856', 'myocarditis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676722, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031054', 'bronchiolitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676723, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008699', 'increased interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676724, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676725, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010758', 'increased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676726, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005410', 'abnormal fertilization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676727, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003475', 'increased summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676728, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008682', 'decreased interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676729, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031242', 'increased CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676730, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676731, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003875', 'abnormal hair follicle regression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676732, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001800', 'abnormal humoral immune response', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676733, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003762', 'abnormal immune organ physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676734, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676735, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676736, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676737, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008681', 'increased interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676738, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013134', 'poor circulation in autopods', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676739, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000327', 'hemosiderinuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676740, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008705', 'increased interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676741, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676742, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010028', 'aciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676743, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676744, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013208', 'abnormal cilium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676745, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008271', 'abnormal bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676746, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006082', 'CNS inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676747, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020039', 'increased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676748, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001634', 'internal hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676749, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676750, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010992', 'increased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676751, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030939', 'abnormal autophagosome formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676752, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010636', 'bundle branch block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676753, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676754, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020080', 'increased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676755, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0021009', 'abnormal synaptic physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676756, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020414', 'abnormal fibroblast physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676757, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676758, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013806', 'encephalopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676759, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003186', 'abnormal redox activity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676760, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003767', 'palate inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676761, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003633', 'abnormal nervous system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676762, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005025', 'abnormal response to infection', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676763, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676764, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002472', 'impaired complement alternative pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676765, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008690', 'increased interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676766, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001862', 'interstitial pneumonia', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676767, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000738', 'impaired muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676768, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001761', 'abnormal urination pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676769, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009348', 'abnormal urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676770, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008687', 'increased interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676771, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676772, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011926', 'abnormal heart valve physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676773, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676774, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676775, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002328', 'abnormal airway resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676776, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012608', 'abnormal complement C5 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676777, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010554', 'shortened HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676778, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004879', 'decreased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676779, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001950', 'abnormal respiratory sounds', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676780, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002322', 'abnormal respiratory transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676781, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004213', 'abnormal umami taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676782, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008544', 'impaired olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676783, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008567', 'decreased interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676784, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030215', 'facial muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676785, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676786, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001835', 'abnormal antigen presentation', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676787, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020381', 'muscle gating pore current', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676788, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676789, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003077', 'abnormal cell cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676790, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004149', 'increased bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676791, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031241', 'decreased CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676792, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676793, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030129', 'tongue inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676794, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676795, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031110', 'meningitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676796, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676797, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003787', 'abnormal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676798, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676799, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008664', 'decreased interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676800, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030118', 'rhinosinusitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676801, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012120', 'trophectoderm cell degeneration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676802, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676803, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676804, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012200', 'increased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676805, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676806, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002409', 'decreased susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676807, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676808, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001921', 'reduced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676809, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000316', 'cellular necrosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676810, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008702', 'increased interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676811, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676812, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676813, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000350', 'abnormal cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676814, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676815, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676816, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011930', 'abnormal tricuspid valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676817, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676818, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001951', 'abnormal breathing pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676819, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676820, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003252', 'abnormal bile duct physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676821, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002296', 'aspiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676822, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003464', 'abnormal single cell response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676823, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003665', 'endophthalmitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676824, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676825, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013639', 'decreased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676826, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676827, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001983', 'abnormal olfactory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676828, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014120', 'focal seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676829, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003298', 'choking', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676830, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008861', 'abnormal hair shedding', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676831, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010553', 'prolonged HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676832, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009567', 'mitotic nondisjunction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676833, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004036', 'abnormal muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676834, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001853', 'heart inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676835, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003251', 'gallbladder inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676836, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010519', 'atrioventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676837, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676838, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020845', 'abnormal DNA-templated transcription', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676839, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010539', 'decreased level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676840, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676841, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001194', 'dermatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676842, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008679', 'decreased interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676843, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001648', 'abnormal apoptosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676844, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001914', 'hemorrhage', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676845, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676846, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003096', 'increased corneal light-scattering', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676847, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001596', 'hypotension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676848, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013475', 'delayed reproductive senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676849, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008950', 'ventricular tachycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676850, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003476', 'decreased summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676851, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002133', 'abnormal respiratory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676852, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031246', 'abnormal CCL3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676853, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020138', 'delayed bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676854, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010680', 'abnormal skin adnexa physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676855, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014132', 'abnormal tear film physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676856, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005275', 'abnormal skin tensile strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676857, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676858, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676859, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010950', 'abnormal lung hysteresivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676860, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014030', 'abnormal mucous gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676861, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676862, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003233', 'prolonged QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676863, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676864, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676865, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676866, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011927', 'abnormal cardiac valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676867, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003157', 'impaired muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676868, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676869, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676870, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676871, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020040', 'decreased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676872, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003901', 'abnormal PR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676873, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001872', 'sinus inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676874, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008002', 'hyperchlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676875, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008666', 'increased interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676876, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676877, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003259', 'nausea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676878, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002999', 'abnormal bone healing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676879, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676880, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005666', 'abnormal adipose tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676881, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003928', 'increased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676882, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001851', 'eye inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676883, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676884, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006114', 'cardiac murmur', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676885, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014046', 'abnormal mitophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676886, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004780', 'abnormal surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676887, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008008', 'early cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676888, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000743', 'muscle spasm', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676889, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008709', 'decreased interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676890, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676891, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676892, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676893, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003741', 'tinnitus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676894, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676895, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003393', 'decreased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676896, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010505', 'abnormal T wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676897, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001533', 'abnormal skeleton physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676898, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020154', 'impaired humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676899, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003261', 'hematemesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676900, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676901, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676902, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676903, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008706', 'decreased interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676904, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009473', 'abnormal skin exfoliation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676905, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676906, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001663', 'abnormal digestive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676907, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009058', 'decreased interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676908, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0021015', 'increased tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676909, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012553', 'decreased serum complement activity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676910, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010071', 'abnormal pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676911, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003122', 'maternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676912, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003341', 'chronic pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676913, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676914, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676915, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000231', 'hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676916, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676917, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676918, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001852', 'conjunctivitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676919, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031129', 'left-to-right shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676920, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676921, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676922, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676923, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010377', 'abnormal gut flora balance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676924, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014037', 'stranguria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676925, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676926, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676927, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020000', 'abnormal response to antigen', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676928, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000343', 'abnormal response to cardiac infarction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676929, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676930, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676931, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008669', 'increased interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676932, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011421', 'cylindruria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676933, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004145', 'abnormal muscle electrophysiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676934, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031111', 'meningoencephalitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676935, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676936, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676937, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008696', 'increased interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676938, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676939, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009792', 'seborrheic dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676940, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008751', 'abnormal interleukin level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676941, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002693', 'abnormal pancreas physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676942, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003280', 'urinary incontinence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676943, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013555', 'abnormal apocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676944, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676945, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676946, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676947, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676948, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676949, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676950, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676951, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005402', 'abnormal action potential', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676952, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676953, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676954, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676955, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031224', 'abnormal CXCL10 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676956, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676957, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676958, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012011', 'febrile seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676959, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676960, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010753', 'improved mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676961, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001945', 'bronchoconstriction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676962, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005575', 'increased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676963, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676964, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676965, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006080', 'brain ischemia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676966, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676967, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676968, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001985', 'abnormal gustatory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676969, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030132', 'periodontium inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676970, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005532', 'abnormal vascular resistance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676971, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001633', 'poor circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676972, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008272', 'abnormal endochondral bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676973, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010993', 'decreased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676974, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002334', 'abnormal airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676975, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010822', 'pneumothorax', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676976, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002333', 'abnormal lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676977, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003254', 'bile duct inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676978, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676979, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013556', 'abnormal holocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676980, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010394', 'decreased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676981, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013627', 'increased vertebra yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676982, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676983, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001873', 'stomach inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676984, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005576', 'decreased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676985, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001867', 'rhinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676986, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676987, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676988, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001864', 'vascular inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676989, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001933', 'abnormal litter size', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676990, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676991, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676992, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676993, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011082', 'abnormal gastrointestinal motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676994, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676995, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010386', 'abnormal urinary bladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676996, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020412', 'abnormal amnion physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676997, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012197', 'impaired myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676998, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030153', 'dental pulp inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(676999, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020386', 'adipose tissue inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677000, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677001, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031302', 'syncope', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677002, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677003, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003483', 'decreased nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677004, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008568', 'abnormal interleukin secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677005, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005403', 'abnormal nerve conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677006, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012382', 'abnormal blood cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677007, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004142', 'abnormal muscle tone', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677008, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011805', 'decreased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677009, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008651', 'increased interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677010, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003480', 'increased nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677011, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001752', 'abnormal hypothalamus secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677012, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004070', 'abnormal P wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677013, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677014, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002254', 'reproductive system inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677015, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002330', 'abnormal bronchial provocation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677016, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677017, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001841', 'decreased level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677018, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677019, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008722', 'abnormal chemokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677020, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002064', 'seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677021, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002406', 'increased susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677022, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005088', 'increased acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677023, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030214', 'muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677024, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005036', 'diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677025, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677026, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003472', 'increased summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677027, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677028, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031480', 'abnormal urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677029, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001861', 'lung inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677030, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003725', 'increased autoantibody level', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677031, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004796', 'increased anti-histone antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677032, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005333', 'decreased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677033, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677034, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677035, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001793', 'abnormal susceptibility to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677036, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677037, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677038, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006266', 'decreased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677039, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002498', 'abnormal acute inflammation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677040, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020001', 'decreased response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677041, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002473', 'impaired complement classical pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677042, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677043, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006001', 'abnormal intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677044, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677045, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008700', 'decreased interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677046, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003882', 'abnormal pulse pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677047, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010756', 'decreased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677048, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011931', 'abnormal pulmonary valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677049, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003482', 'increased nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677050, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013136', 'genital discharge', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677051, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009789', 'decreased susceptibility to bacterial infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677052, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031222', 'decreased CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677053, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003292', 'melena', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677054, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011044', 'increased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677055, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677056, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677057, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031469', 'abnormal pinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677058, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677059, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003306', 'small intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677060, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010504', 'abnormal RR interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677061, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030216', 'tongue muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677062, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010741', 'abnormal melanocyte proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677063, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677064, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677065, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003889', 'enhanced sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677066, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003394', 'increased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677067, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001756', 'abnormal urination', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677068, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677069, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006265', 'increased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677070, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009275', 'bruising', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677071, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677072, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004484', 'abnormal response of heart to induced stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677073, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001850', 'increased susceptibility to otitis media', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677074, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012556', 'increased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677075, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013559', 'abnormal exocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677076, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677077, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002934', 'acute joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677078, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008564', 'increased interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677079, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677080, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001313', 'increased incidence of corneal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677081, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013479', 'scleritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677082, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011951', 'increased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677083, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031169', 'abnormal joint physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677084, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000304', 'abnormal cardiac stroke volume', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677085, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001627', 'abnormal cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677086, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677087, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677088, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005580', 'periinsulitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677089, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677090, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677091, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003468', 'increased single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677092, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003698', 'abnormal male reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677093, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005671', 'abnormal response to transplant', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677094, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005087', 'decreased acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677095, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677096, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677097, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008678', 'increased interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677098, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003260', 'vomiting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677099, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008003', 'achlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677100, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677101, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677102, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677103, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677104, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005076', 'abnormal cell differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677105, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012111', 'failure of morula compaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677106, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677107, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677108, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008673', 'decreased interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677109, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002896', 'abnormal bone mineralization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677110, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011763', 'urethritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677111, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677112, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002418', 'increased susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677113, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000313', 'abnormal cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677114, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005190', 'osteomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677115, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031090', 'ageusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677116, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002420', 'abnormal adaptive immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677117, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677118, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031226', 'increased CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677119, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004211', 'abnormal sour taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677120, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006042', 'increased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677121, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002164', 'abnormal gland physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677122, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677123, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031013', 'abnormal egg activation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677124, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677125, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001912', 'increased cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677126, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010515', 'abnormal Q wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677127, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002842', 'increased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677128, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003900', 'shortened QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677129, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677130, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010957', 'abnormal aerobic respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677131, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012554', 'increased serum complement activity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677132, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677133, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011043', 'abnormal lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677134, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008703', 'decreased interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677135, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031105', 'rhonchi', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677136, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677137, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677138, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002128', 'abnormal blood circulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677139, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677140, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004759', 'decreased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677141, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001986', 'abnormal taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677142, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010538', 'increased level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677143, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011936', 'abnormal PP interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677144, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005253', 'abnormal eye physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677145, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002933', 'joint inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677146, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677147, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008663', 'increased interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677148, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003868', 'abnormal feces composition', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677149, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008744', 'abnormal B cell anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677150, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031240', 'abnormal CSF3 level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677151, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003471', 'abnormal summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677152, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009045', 'muscle tetany', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677153, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677154, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008684', 'increased interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677155, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002090', 'abnormal vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677156, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677157, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011952', 'decreased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677158, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014275', 'increased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677159, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011918', 'abnormal PQ interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677160, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003777', 'lip inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677161, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009645', 'crystalluria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677162, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011418', 'leukocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677163, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002998', 'abnormal bone remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677164, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003621', 'dysuria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677165, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013561', 'abnormal endocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677166, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677167, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005001', 'abnormal clonal deletion', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677168, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031128', 'cardiovascular shunt', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677169, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003866', 'abnormal defecation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677170, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006043', 'decreased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677171, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030822', 'sacroiliac joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677172, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008566', 'increased interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677173, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020218', 'abnormal tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677174, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031424', 'enhanced female fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677175, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011045', 'decreased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677176, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009791', 'increased susceptibility to viral infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677177, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001664', 'abnormal digestion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677178, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003039', 'increased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677179, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677180, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677181, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677182, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008995', 'early reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677183, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677184, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001857', 'pericarditis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677185, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677186, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677187, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677188, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677189, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008750', 'abnormal interferon level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677190, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003880', 'abnormal central pattern generator function', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677191, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677192, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011762', 'renal/urinary system inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677193, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020848', 'abnormal exocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677194, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677195, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677196, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677197, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003820', 'increased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677198, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677199, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031130', 'right-to-left shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677200, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001542', 'abnormal bone strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677201, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002841', 'impaired skeletal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677202, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677203, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008747', 'abnormal T cell anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677204, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020096', 'high mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677205, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013460', 'periocular dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677206, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010073', 'decreased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677207, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677208, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003674', 'oxidative stress', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677209, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003726', 'decreased autoantibody level', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677210, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013637', 'increased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677211, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008676', 'decreased interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677212, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010155', 'abnormal intestine physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677213, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677214, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003477', 'abnormal nerve fiber response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677215, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011518', 'abnormal cell chemotaxis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677216, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012745', 'abnormal neural crest cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677217, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013632', 'increased femur maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677218, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031088', 'coughing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677219, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677220, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677221, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031248', 'increased CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677222, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677223, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001858', 'intestinal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677224, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677225, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005364', 'increased susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677226, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677227, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677228, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001943', 'abnormal respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677229, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010552', 'abnormal HV interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677230, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011432', 'decreased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677231, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677232, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677233, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677234, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031247', 'decreased CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677235, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677236, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006046', 'atrioventricular valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677237, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030938', 'abnormal reticulophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677238, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677239, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011920', 'abnormal S wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677240, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030909', 'abnormal melanocyte adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677241, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004122', 'abnormal sinus arrhythmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677242, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0012609', 'decreased complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677243, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008713', 'abnormal cytokine level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677244, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677245, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003878', 'abnormal ear physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677246, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677247, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0006002', 'abnormal small intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677248, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677249, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008562', 'increased interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677250, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031051', 'lymph node hemorrhage', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677251, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009698', 'heart hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677252, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003560', 'osteoarthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677253, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002161', 'abnormal fertility/fecundity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677254, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677255, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001844', 'autoimmune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677256, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677257, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009344', 'abnormal ovulation cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677258, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677259, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030991', 'optic nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677260, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677261, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004011', 'decreased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677262, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677263, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003823', 'increased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677264, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004947', 'skin inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677265, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677266, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010895', 'increased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677267, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677268, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031086', 'wheezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677269, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004752', 'decreased length of allograft survival', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677270, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010571', 'shortened ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677271, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009661', 'abnormal pregnancy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677272, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677273, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003011', 'delayed dark adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677274, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001840', 'increased level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677275, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008539', 'decreased susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677276, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031053', 'pleuritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677277, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677278, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0010954', 'abnormal cellular respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677279, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002327', 'abnormal respiratory function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677280, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011048', 'decreased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677281, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677282, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020147', 'abnormal defecation amount', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677283, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677284, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011420', 'pyuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677285, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0009562', 'abnormal odor adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677286, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677287, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008776', 'increased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677288, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002578', 'impaired ability to fire action potentials', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677289, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002405', 'respiratory system inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677290, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011012', 'bronchiectasis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677291, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677292, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004037', 'increased muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677293, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0000352', 'decreased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677294, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0031425', 'enhanced male fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677295, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008688', 'decreased interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677296, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003304', 'large intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677297, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004072', 'abnormal frontal plane axis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677298, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0002626', 'increased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677299, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0003340', 'acute pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677300, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008660', 'increased interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677301, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0004031', 'insulitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677302, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677303, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008708', 'increased interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677304, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0030987', 'spinal cord inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677305, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(677306, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0011047', 'increased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677307, 'HP:0001983', 'Reduced lymphocyte surface expression of CD43', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677308, 'HP:0100720', 'Hypoplasia of the ear cartilage', 'MP:0030297', 'outer ear hypoplasia', 0.4107142857142857, 14.732678149995134, 2.4598620658552615, 'UPHENO:0080110', 'aplasia or hypoplasia of external ear'),
(677309, 'HP:0100720', 'Hypoplasia of the ear cartilage', 'MP:0000022', 'abnormal ear shape', 0.5208333333333334, 11.115294171581601, 2.406078908590784, 'UPHENO:0005986', 'abnormal shape of external ear'),
(677310, 'HP:0100720', 'Hypoplasia of the ear cartilage', 'MP:0000018', 'small ears', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(677311, 'HP:0100720', 'Hypoplasia of the ear cartilage', 'MP:0006290', 'proboscis', 0.4166666666666667, 6.5236679405794336, 1.6486949309200385, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(677312, 'HP:0100720', 'Hypoplasia of the ear cartilage', 'MP:0009578', 'otocephaly', 0.4166666666666667, 6.5236679405794336, 1.6486949309200385, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(677313, 'HP:0100720', 'Hypoplasia of the ear cartilage', 'MP:0003736', 'folded helix', 0.423728813559322, 11.115294171581601, 2.170223585644373, 'UPHENO:0005986', 'abnormal shape of external ear'),
(677314, 'HP:0100720', 'Hypoplasia of the ear cartilage', 'MP:0003735', 'cup-shaped ears', 0.46296296296296297, 11.115294171581601, 2.268472949779294, 'UPHENO:0005986', 'abnormal shape of external ear'),
(677315, 'HP:0100720', 'Hypoplasia of the ear cartilage', 'MP:0000017', 'big ears', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(677316, 'HP:0100720', 'Hypoplasia of the ear cartilage', 'MP:0011495', 'abnormal head shape', 0.425531914893617, 6.5236679405794336, 1.6661419239923307, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(677317, 'HP:0000904', 'Flaring of rib cage', 'MP:0004673', 'splayed ribs', 0.49122807017543857, 12.66854781257542, 2.494623477380243, 'UPHENO:0031135', 'abnormal anatomical entity, splayed'),
(677318, 'HP:0000904', 'Flaring of rib cage', 'MP:0010099', 'abnormal thoracic cage shape', 0.4423076923076923, 15.384754846574829, 2.608600278484248, 'UPHENO:0005988', 'abnormal shape of thoracic rib cage'),
(677319, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677320, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677321, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0000951', 'sporadic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677322, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677323, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677324, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0012011', 'febrile seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677325, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003482', 'increased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677326, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003480', 'increased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677327, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677328, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677329, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677330, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677331, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0013806', 'encephalopathy', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677332, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003889', 'enhanced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677333, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003474', 'abnormal summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677334, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003467', 'abnormal single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677335, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677336, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0014120', 'focal seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677337, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677338, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677339, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677340, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677341, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677342, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677343, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0008814', 'decreased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677344, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003475', 'increased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677345, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677346, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677347, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677348, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003633', 'abnormal nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677349, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677350, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0021009', 'abnormal synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677351, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003465', 'increased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677352, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003880', 'abnormal central pattern generator function', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677353, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0011994', 'increased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677354, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0012006', 'abnormal hippocampus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677355, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677356, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677357, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003466', 'decreased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677358, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003464', 'abnormal single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677359, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677360, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0021015', 'increased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677361, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677362, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0002578', 'impaired ability to fire action potentials', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677363, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677364, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677365, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003473', 'decreased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677366, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677367, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0002634', 'abnormal sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677368, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677369, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003477', 'abnormal nerve fiber response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677370, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0002064', 'seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677371, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003471', 'abnormal summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677372, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677373, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0006080', 'brain ischemia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677374, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0000948', 'nonconvulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677375, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0000947', 'convulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677376, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677377, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003468', 'increased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677378, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003470', 'abnormal summary potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677379, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003476', 'decreased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677380, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0002635', 'reduced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677381, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0005402', 'abnormal action potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677382, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0004994', 'abnormal brain wave pattern', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677383, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0005403', 'abnormal nerve conduction', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677384, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003469', 'decreased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677385, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003463', 'abnormal single cell response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677386, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0003472', 'increased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677387, 'HP:0012018', 'EEG with temporal focal spikes', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(677388, 'HP:0001025', 'Urticaria', 'MP:0031103', 'skin rash', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677389, 'HP:0001025', 'Urticaria', 'MP:0003853', 'dry skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677390, 'HP:0001025', 'Urticaria', 'MP:0011239', 'abnormal skin coloration', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677391, 'HP:0001025', 'Urticaria', 'MP:0001208', 'blistering', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677392, 'HP:0001025', 'Urticaria', 'MP:0008816', 'petechiae', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677393, 'HP:0001025', 'Urticaria', 'MP:0001210', 'skin ridges', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677394, 'HP:0001025', 'Urticaria', 'MP:0002897', 'blotchy skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677395, 'HP:0001025', 'Urticaria', 'MP:0009931', 'abnormal skin appearance', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677396, 'HP:0001025', 'Urticaria', 'MP:0008854', 'bleb', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677397, 'HP:0001025', 'Urticaria', 'MP:0001196', 'shiny skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677398, 'HP:0001025', 'Urticaria', 'MP:0001213', 'abnormal skin cell number', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677399, 'HP:0001025', 'Urticaria', 'MP:0001193', 'psoriasis', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677400, 'HP:0001025', 'Urticaria', 'MP:0001191', 'abnormal skin condition', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677401, 'HP:0001025', 'Urticaria', 'MP:0009827', 'skin detachment', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677402, 'HP:0001025', 'Urticaria', 'MP:0008856', 'fetal bleb', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677403, 'HP:0001025', 'Urticaria', 'MP:0003717', 'pallor', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677404, 'HP:0001025', 'Urticaria', 'MP:0001243', 'abnormal dermal layer morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677405, 'HP:0001025', 'Urticaria', 'MP:0011515', 'purpura', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677406, 'HP:0001025', 'Urticaria', 'MP:0001195', 'flaky skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677407, 'HP:0001025', 'Urticaria', 'MP:0001212', 'skin lesions', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677408, 'HP:0001025', 'Urticaria', 'MP:0003941', 'abnormal skin development', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677409, 'HP:0001025', 'Urticaria', 'MP:0009563', 'dyskeratosis', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677410, 'HP:0001025', 'Urticaria', 'MP:0005421', 'loose skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677411, 'HP:0001025', 'Urticaria', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.4117647058823529, 7.4735768925632104, 1.7542392057685403, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677412, 'HP:0001025', 'Urticaria', 'MP:0002060', 'abnormal skin morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677413, 'HP:0001025', 'Urticaria', 'MP:0001198', 'tight skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677414, 'HP:0001025', 'Urticaria', 'MP:0012078', 'abnormal tail ring morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677415, 'HP:0001025', 'Urticaria', 'MP:0009441', 'delayed skin barrier formation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677416, 'HP:0001025', 'Urticaria', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677417, 'HP:0001025', 'Urticaria', 'MP:0001192', 'scaly skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677418, 'HP:0001025', 'Urticaria', 'MP:0003652', 'abnormal skin turgor', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677419, 'HP:0001025', 'Urticaria', 'MP:0001201', 'translucent skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677420, 'HP:0001025', 'Urticaria', 'MP:0001216', 'abnormal epidermal layer morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(677421, 'HP:0100339', 'Abnormality of the os naviculare pedis', 'MP:0009727', 'abnormal navicular morphology', 0.41379310344827586, 15.384754846574829, 2.5231142371591306, 'UPHENO:0075912', 'abnormal navicular bone of pes'),
(677422, 'HP:0100339', 'Abnormality of the os naviculare pedis', 'MP:0005104', 'abnormal tarsal bone morphology', 0.4107142857142857, 11.834557764014347, 2.204681822574769, 'UPHENO:0002920', 'abnormal tarsal bone'),
(677423, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0002001', 'blindness', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677424, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012151', 'increased a-wave latency', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677425, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0004022', 'abnormal cone electrophysiology', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677426, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020220', 'decreased tear production', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677427, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0003100', 'myopia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677428, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012146', 'increased b-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677429, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020979', 'decreased FO-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677430, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0004021', 'abnormal rod electrophysiology', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677431, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0011832', 'abnormal visual acuity', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677432, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0008145', 'hemeralopia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677433, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012031', 'abnormal b-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677434, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0006150', 'double vision', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677435, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677436, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020861', 'abnormal corneal wound healing', 0.43902439024390244, 8.795504987450572, 1.9650550155155173, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677437, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012148', 'decreased a-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677438, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012154', 'decreased b-wave latency', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677439, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020958', 'abnormal c-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677440, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0010748', 'abnormal visual evoked potential', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677441, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0001999', 'photosensitivity', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677442, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0014157', 'alacrima', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677443, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012037', 'abnormal b-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677444, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012153', 'increased b-wave latency', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677445, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0005258', 'ocular hypertension', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677446, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020977', 'decreased FO-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677447, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0006149', 'decreased visual acuity', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677448, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0005253', 'abnormal eye physiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677449, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020959', 'decreased c-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677450, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677451, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020978', 'abnormal FO-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677452, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677453, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012038', 'abnormal a-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677454, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012040', 'abnormal c-wave shape', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677455, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012145', 'increased a-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677456, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0013145', 'eye discharge', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677457, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0011275', 'abnormal behavioral response to light', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677458, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012144', 'decreased b-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677459, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0006153', 'hypermetropia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677460, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0005260', 'ocular hypotension', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677461, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012039', 'abnormal b-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677462, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012033', 'abnormal ERG implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677463, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020860', 'abnormal cornea physiology', 0.4864864864864865, 8.795504987450572, 2.0685488435662327, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677464, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020975', 'abnormal FO-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677465, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677466, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0005551', 'abnormal eye electrophysiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677467, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0001389', 'abnormal eye movement', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677468, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0003011', 'delayed dark adaptation', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677469, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0006251', 'eyelid apraxia', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677470, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012050', 'decreased susceptilbility to retina ischemic injury', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677471, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677472, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0014132', 'abnormal tear film physiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677473, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0006072', 'abnormal retina apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677474, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0006147', 'monocular blindness', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677475, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012035', 'abnormal b-wave shape', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677476, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0006224', 'oculomotor apraxia', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677477, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0003096', 'increased corneal light-scattering', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677478, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012143', 'decreased a-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677479, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012034', 'abnormal a-wave shape', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677480, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012032', 'abnormal ERG latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677481, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0010749', 'absent visual evoked potential', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677482, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0006145', 'legal blindness', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677483, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0001337', 'dry eyes', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677484, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020218', 'abnormal tear production', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677485, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0014179', 'abnormal blood-retina barrier function', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677486, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0003101', 'high myopia', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677487, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0006152', 'tunnel vision', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677488, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0001851', 'eye inflammation', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677489, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0008795', 'abnormal lens fiber apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677490, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0008793', 'abnormal lens epithelium apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677491, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020439', 'absent b-wave', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677492, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020974', 'abnormal FO-wave shape', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677493, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0002090', 'abnormal vision', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677494, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020963', 'decreased c-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677495, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0006148', 'binocular blindness', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677496, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020960', 'increased c-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677497, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012030', 'abnormal a-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677498, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012149', 'decreased b-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677499, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020961', 'abnormal c-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677500, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0005257', 'abnormal intraocular pressure', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677501, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012152', 'decreased a-wave latency', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677502, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012147', 'increased a-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677503, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012036', 'abnormal a-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677504, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020980', 'increased FO-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677505, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012150', 'increased b-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677506, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0031497', 'increased visual acuity', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677507, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0006190', 'retina ischemia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677508, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020976', 'increased FO-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677509, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020219', 'increased tear production', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677510, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0020962', 'increased c-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677511, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0013468', 'chromodacryorrhea', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677512, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0008144', 'nyctalopia', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677513, 'HP:0030482', 'Abnormal timing of light-adapted single flash electroretinogram', 'MP:0012049', 'increased susceptilbility to retina ischemic injury', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(677514, 'HP:0012468', 'Chronic acidosis', 'MP:0012552', 'lactic acidosis', 0.475, 9.101997348968142, 2.0792904416554863, 'UPHENO:0082539', 'increased bodily fluid role level'),
(677515, 'HP:0009019', 'Progressive loss of facial adipose tissue', 'MP:0001783', 'decreased white adipose tissue amount', 0.44, 13.33412877350486, 2.422192531641971, 'UPHENO:0063854', 'abnormally decreased number of adipose tissue'),
(677516, 'HP:0009019', 'Progressive loss of facial adipose tissue', 'MP:0001780', 'decreased brown adipose tissue amount', 0.44, 13.33412877350486, 2.422192531641971, 'UPHENO:0063854', 'abnormally decreased number of adipose tissue'),
(677517, 'HP:0009019', 'Progressive loss of facial adipose tissue', 'MP:0010025', 'decreased total body fat amount', 0.5, 13.33412877350486, 2.5820659144863884, 'UPHENO:0063854', 'abnormally decreased number of adipose tissue'),
(677518, 'HP:0009019', 'Progressive loss of facial adipose tissue', 'MP:0008853', 'decreased abdominal adipose tissue amount', 0.4583333333333333, 13.33412877350486, 2.472139900542927, 'UPHENO:0063854', 'abnormally decreased number of adipose tissue'),
(677519, 'HP:0034958', 'Asymmetrical insertion of the midpiece into the head', 'MP:0001124', 'abnormal gametes', 0.4186046511627907, 10.791230332350247, 2.1253844849557932, 'UPHENO:0085194', 'abnormal gamete'),
(677520, 'HP:0034958', 'Asymmetrical insertion of the midpiece into the head', 'MP:0006362', 'abnormal male germ cell morphology', 0.4186046511627907, 11.607147267911277, 2.204269909307646, 'UPHENO:0084945', 'abnormal male germ cell morphology'),
(677521, 'HP:0034958', 'Asymmetrical insertion of the midpiece into the head', 'MP:0020550', 'multinucleated giant male germ cells', 0.4090909090909091, 11.607147267911277, 2.179077425834586, 'UPHENO:0084945', 'abnormal male germ cell morphology'),
(677522, 'HP:0034958', 'Asymmetrical insertion of the midpiece into the head', 'MP:0005578', 'teratozoospermia', 0.41304347826086957, 11.607147267911277, 2.1895790646204634, 'UPHENO:0084945', 'abnormal male germ cell morphology'),
(677523, 'HP:0034958', 'Asymmetrical insertion of the midpiece into the head', 'MP:0002208', 'abnormal germ cell morphology', 0.40476190476190477, 10.700256672302757, 2.0811189951856535, 'UPHENO:0084966', 'abnormal germ cell morphology'),
(677524, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677525, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677526, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677527, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677528, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677529, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005000', 'abnormal immune tolerance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677530, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677531, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020154', 'impaired humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677532, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677533, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677534, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677535, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677536, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677537, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002471', 'abnormal complement pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677538, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677539, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031095', 'pharyngitis', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677540, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677541, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677542, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677543, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677544, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677545, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677546, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0030129', 'tongue inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677547, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031102', 'rhinorrhea', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677548, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677549, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677550, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677551, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677552, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677553, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677554, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677555, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677556, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677557, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677558, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677559, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677560, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677561, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677562, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677563, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677564, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0030002', 'increased lung apoptosis', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677565, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010368', 'abnormal lymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677566, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677567, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677568, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677569, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677570, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677571, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0014274', 'decreased respiration', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677572, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001872', 'sinus inflammation', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677573, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001837', 'defective assembly of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677574, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677575, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677576, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677577, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677578, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677579, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677580, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677581, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001844', 'autoimmune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677582, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677583, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677584, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677585, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677586, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013127', 'epistaxis', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677587, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677588, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677589, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677590, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677591, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677592, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677593, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0030153', 'dental pulp inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677594, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677595, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003660', 'chylothorax', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677596, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677597, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677598, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677599, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677600, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677601, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677602, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001867', 'rhinitis', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677603, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677604, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677605, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677606, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677607, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677608, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008747', 'abnormal T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677609, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677610, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677611, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677612, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010992', 'increased surfactant secretion', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677613, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677614, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677615, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677616, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677617, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677618, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677619, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005005', 'abnormal self tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677620, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677621, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677622, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011045', 'decreased lung elastance', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677623, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013498', 'trachea inflammation', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677624, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002330', 'abnormal bronchial provocation', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677625, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677626, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677627, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677628, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677629, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031055', 'bronchitis', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677630, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677631, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677632, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677633, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677634, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677635, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677636, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677637, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677638, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677639, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677640, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677641, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010334', 'pleural effusion', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677642, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677643, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677644, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677645, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002420', 'abnormal adaptive immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677646, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677647, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001951', 'abnormal breathing pattern', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677648, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011043', 'abnormal lung elastance', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677649, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677650, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677651, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005044', 'sepsis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677652, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677653, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002335', 'decreased airway responsiveness', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677654, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001861', 'lung inflammation', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677655, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677656, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012124', 'increased bronchoconstrictive response', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677657, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677658, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677659, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005575', 'increased pulmonary ventilation', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677660, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677661, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677662, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677663, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677664, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010946', 'hyperpnea', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677665, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001835', 'abnormal antigen presentation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677666, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677667, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677668, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677669, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005573', 'increased pulmonary respiratory rate', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677670, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677671, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677672, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677673, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002296', 'aspiration', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677674, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677675, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677676, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005576', 'decreased pulmonary ventilation', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677677, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677678, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001793', 'abnormal susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677679, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677680, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677681, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677682, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677683, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677684, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677685, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677686, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677687, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677688, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677689, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677690, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002500', 'granulomatous inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677691, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005025', 'abnormal response to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677692, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677693, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677694, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008744', 'abnormal B cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677695, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010895', 'increased lung compliance', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677696, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677697, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677698, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020000', 'abnormal response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677699, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677700, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677701, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677702, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677703, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677704, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677705, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677706, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677707, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677708, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677709, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031307', 'bronchomalacia', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677710, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677711, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677712, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677713, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677714, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0014028', 'decreased respiratory epithelial chloride transmembrane transport', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677715, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677716, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677717, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001790', 'abnormal immune system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677718, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677719, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677720, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677721, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677722, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677723, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020002', 'increased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677724, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031104', 'crackles', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677725, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677726, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004782', 'abnormal surfactant physiology', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677727, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677728, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677729, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677730, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677731, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677732, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677733, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677734, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677735, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677736, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031053', 'pleuritis', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677737, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677738, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677739, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010753', 'improved mucociliary clearance', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677740, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677741, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677742, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003777', 'lip inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677743, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677744, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677745, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677746, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677747, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677748, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677749, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677750, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677751, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677752, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677753, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677754, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677755, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031086', 'wheezing', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677756, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004751', 'increased length of allograft survival', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677757, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677758, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677759, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677760, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677761, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677762, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013752', 'stridor', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677763, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677764, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677765, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677766, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677767, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677768, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677769, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677770, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013753', 'tracheomalacia', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677771, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677772, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677773, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010896', 'decreased lung compliance', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677774, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677775, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677776, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677777, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677778, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677779, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677780, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677781, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677782, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677783, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677784, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677785, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677786, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677787, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677788, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011047', 'increased lung tissue damping', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677789, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677790, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677791, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677792, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677793, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677794, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002322', 'abnormal respiratory transport', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677795, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677796, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677797, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677798, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002498', 'abnormal acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677799, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005671', 'abnormal response to transplant', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677800, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677801, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677802, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677803, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677804, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012550', 'respiratory acidosis', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677805, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031308', 'tracheobronchomalacia', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677806, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002133', 'abnormal respiratory system physiology', 0.5833333333333334, 8.526773851447254, 2.230235730442913, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677807, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005574', 'decreased pulmonary respiratory rate', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677808, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002419', 'abnormal innate immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677809, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677810, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677811, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677812, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020001', 'decreased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677813, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677814, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677815, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677816, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677817, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031089', 'sneezing', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677818, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677819, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677820, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677821, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677822, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001846', 'increased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677823, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677824, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677825, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677826, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677827, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677828, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677829, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677830, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677831, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677832, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677833, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001943', 'abnormal respiration', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677834, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004781', 'abnormal surfactant composition', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677835, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020844', 'abnormal pulmonary respiratory rate response', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677836, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677837, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004752', 'decreased length of allograft survival', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677838, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004780', 'abnormal surfactant secretion', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677839, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677840, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677841, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677842, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002327', 'abnormal respiratory function', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677843, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002338', 'abnormal pulmonary ventilation', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677844, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677845, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677846, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010936', 'decreased airway resistance', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677847, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677848, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010935', 'increased airway resistance', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677849, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677850, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677851, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001947', 'abnormal mucociliary clearance', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677852, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677853, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005426', 'tachypnea', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677854, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677855, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677856, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677857, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002314', 'abnormal respiratory mechanics', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677858, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003762', 'abnormal immune organ physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677859, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0030132', 'periodontium inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677860, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677861, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677862, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005001', 'abnormal clonal deletion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677863, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677864, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677865, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677866, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677867, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677868, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677869, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003009', 'abnormal cytokine secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677870, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677871, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677872, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677873, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677874, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001950', 'abnormal respiratory sounds', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677875, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677876, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677877, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677878, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677879, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677880, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677881, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008722', 'abnormal chemokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677882, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677883, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002334', 'abnormal airway responsiveness', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677884, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677885, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677886, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677887, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001952', 'increased airway responsiveness', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677888, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677889, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677890, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677891, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0014182', 'decreased respiratory epithelial sodium ion transmembrane transport', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677892, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677893, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677894, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677895, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677896, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677897, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677898, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677899, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001866', 'nasal inflammation', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677900, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008568', 'abnormal interleukin secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677901, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0014029', 'increased respiratory epithelial chloride transmembrane transport', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677902, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677903, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677904, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677905, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677906, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001957', 'apnea', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677907, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002333', 'abnormal lung compliance', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677908, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031088', 'coughing', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677909, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010950', 'abnormal lung hysteresivity', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677910, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677911, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677912, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677913, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677914, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001845', 'abnormal inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677915, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002499', 'chronic inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677916, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677917, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001953', 'respiratory failure', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677918, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001800', 'abnormal humoral immune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677919, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677920, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677921, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677922, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677923, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677924, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677925, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677926, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677927, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677928, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677929, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677930, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677931, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677932, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001954', 'respiratory distress', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677933, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677934, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677935, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677936, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002328', 'abnormal airway resistance', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677937, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031105', 'rhonchi', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677938, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677939, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677940, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677941, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677942, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677943, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677944, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677945, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677946, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677947, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677948, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677949, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677950, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677951, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677952, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677953, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677954, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002421', 'abnormal cell-mediated immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677955, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677956, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677957, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677958, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677959, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005572', 'abnormal pulmonary respiratory rate', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677960, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677961, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0014183', 'increased respiratory epithelial sodium ion transmembrane transport', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677962, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0014275', 'increased respiration', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677963, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677964, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677965, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677966, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677967, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677968, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677969, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677970, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011048', 'decreased lung tissue damping', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677971, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677972, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677973, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677974, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677975, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677976, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677977, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011044', 'increased lung elastance', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677978, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677979, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677980, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010993', 'decreased surfactant secretion', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677981, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677982, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677983, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677984, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677985, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0012125', 'decreased bronchoconstrictive response', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677986, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677987, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677988, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001956', 'hypopnea', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677989, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677990, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677991, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0031098', 'abnormal sputum production', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(677992, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0002723', 'abnormal immune serum protein physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677993, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677994, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677995, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677996, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677997, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677998, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(677999, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(678000, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(678001, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(678002, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0010922', 'alveolitis', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(678003, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(678004, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(678005, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(678006, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(678007, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(678008, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(678009, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001876', 'decreased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(678010, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(678011, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0001945', 'bronchoconstriction', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(678012, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0008555', 'abnormal interferon secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(678013, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(678014, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(678015, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0003298', 'choking', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(678016, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0005004', 'abnormal lymphocyte anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(678017, 'HP:0032360', 'Decreased pre-bronchodilator forced expiratory flow 25-75%', 'MP:0020155', 'enhanced humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
